Literature DB >> 11203179

Treatment of subhyaloid haemorrhage with intravitreal tissue plasminogen activator and C3F8 gas injection.

H J Koh, S H Kim, S C Lee, O W Kwon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11203179      PMCID: PMC1723300          DOI: 10.1136/bjo.84.11.1318l

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  7 in total

1.  [Acute monocular visual loss in a child with acute lymphoblastic leukemia].

Authors:  F N Fries; M Bischoff; B Käsmann-Kellner; T Hager; B Seitz; A Viestenz
Journal:  Ophthalmologe       Date:  2016-08       Impact factor: 1.059

2.  Sub-inner limiting membrane haemorrhage: causes and treatment with vitrectomy.

Authors:  Karolien De Maeyer; Rita Van Ginderdeuren; Laurence Postelmans; Peter Stalmans; Joachim Van Calster
Journal:  Br J Ophthalmol       Date:  2007-01-17       Impact factor: 4.638

3.  [Spontaneous macula hemorrhage. Subhyaloid/sub-inner limiting membrane (ILM)].

Authors:  D Völcker; B Junker; L L Hansen
Journal:  Ophthalmologe       Date:  2012-07       Impact factor: 1.059

4.  Long-term evolution of Valsalva retinopathy: a case series.

Authors:  Miriam García Fernández; Joaquín Castro Navarro; Carmen González Castaño
Journal:  J Med Case Rep       Date:  2012-10-10

5.  Macular hole formation after pars plana vitrectomy for the treatment of Valsalva retinopathy: a case report.

Authors:  Kook Young Kim; Seung-Young Yu; Moosang Kim; Hyung Woo Kwak
Journal:  Korean J Ophthalmol       Date:  2014-01-21

6.  High altitude subhyaloid hemorrhage.

Authors:  Abdul Hanifudin; Lik Thai Lim; Elliott Yann Ah-Kee; Tarek El-Khashab
Journal:  Oman J Ophthalmol       Date:  2015 Sep-Dec

7.  Sub-internal limiting membrane hemorrhage treated with intravitreal tissue plasminogen activator followed by octafluoropropane gas injection.

Authors:  Yu-Kang Chou; Yi-Ming Huang; Po-Kang Lin
Journal:  Taiwan J Ophthalmol       Date:  2014-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.